Source recordFED

Arch Biopartners Inc.

Federal grants & contributions· Industrial Research Assistance Program – Contributions to Firms· National Research Council Canada· FY2019· $200,000· BN 101328227· ON

Description

LSALT is a peptide drug and a selective non-enzymatic dipeptidase-1 antagonist and prevents leukocyte adhesion to endothelial cells creating numerous indications for targeting inflammation in the context of microbial and non-microbial (ster…

Amendment chain · 2 entries

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $200,000 at start, $200,000 after amendment #1 (+$0).

$200,000$0Original · 2019-01-01 (start date) · total $200,000Amendment 1 · 2020-10-29 · total $200,000
  • #02019-01-01$200,000
  • #12020-10-29$200,000
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2019-01-01(start date)$200,000—LSALT is a peptide drug and a selective non-enzymatic dipeptidase-1 antagonist and prevents leukocyte adhesion…
#1 amendment2020-10-29$200,000+$0LSALT is a peptide drug and a selective non-enzymatic dipeptidase-1 antagonist and prevents leukocyte adhesion…

Related records · 7

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 101328227)

RefDepartment · programCurrent valueFY
172-2022-2023-Q4-1003639National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$4,000,000FY2023
033-2020-2021-Q3-513415Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SIF Stream 1- R&D$5,407,235FY2021

Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2025-2026-Q2-1034675Mediphage Bioceuticals, Inc.FY2027$63,380FY2027
172-2025-2026-Q3-1037522OBKIO INC.FY2026$50,000FY2026
172-2025-2026-Q3-1037889SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INCFY2026$25,000FY2026
172-2025-2026-Q2-1034040Griffith Foods LimitedFY2026$54,880FY2026
172-2025-2026-Q3-1037273Apollo Machine & Welding Ltd.FY2026$230,000FY2026

Cite as: Glassbox record view · Federal grants & contributions · 172-2018-2019-Q4-919337 · retrieved 2026-11-16.